Correction (DOI:10.1016/j.ajo.2007.01.044);Does "Off-Label" Mean Off Limits for Patient Care?

American Journal of Ophthalmology

Volumn 143, Issue 5, 2007, Pages 853-855

  Parrish II, Richard ^a   Sternberg Jr , Paul ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALTEPLASE; ANTIMETABOLITE; CORTICOSTEROID; CYCLOSPORIN; DOXYCYCLINE; EDETATE DISODIUM; FLUOROURACIL; MINOCYCLINE; MITOMYCIN C; TISSUE PLASMINOGEN ACTIVATOR; TRIAMCINOLONE ACETONIDE;

CATARACT EXTRACTION; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG LABELING; DRUG SAFETY; EDITORIAL; ENDOPHTHALMITIS; EYE INFLAMMATION; FOOD AND DRUG ADMINISTRATION; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MEDICAL PRACTICE; OFF LABEL DRUG USE; PATIENT CARE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA EDEMA; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; TRABECULECTOMY; VISUAL DISORDER;

EID: 34247277521     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.05.012     Document Type: Erratum

References (15)

1. Concise Oxford American Dictionary (2006), Oxford University Press, New York, New York 614
2. Off-label use of medications in ophthalmology. Available at: http://www.google.com/search?hl=en&lr=&q=off-label+use+of+medica tions+in+ophthalmology&btnG=Search. Accessed Date: January 5, 2007.
3. Rhee D.J., Rapuano C.J., Belzer T.L., and Fraunfelder F.W. Off-label drug applications in ophthalmology. In: Rhee D.J., Rapuano C.J., Belzer T.L., and Fraunfelder F.W. (Eds). Physicians' desk reference for ophthalmic medicines (2005), Thomson PDR, Montvale 18-19 PDR 34 edition 2006
4. Pearlman M.D. Prophylactic subconjunctival penicillin and streptomycin after cataract extraction. Arch Ophthalmol 55 (1956) 516-518
5. Chula T.A., Starr M.B., and Musket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 109 (2002) 13-26
6. Starita R.J., Fellman R.L., Spaeth G.L., et al. Short- and long-term effects of postoperative corticosteroids on trabeculectomy. Ophthalmology 92 (1985) 938-946
7. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 121 (1996) 349-366
8. Katz G.J., Higginbotham E.J., Lichter P.R., et al. Mitomycin C vs 5-fluorouracil in high-risk glaucoma filtering surgery: extended follow-up. Ophthalmology 102 (1995) 1263-1269
9. Kitazawa Y., Kawase K., Matsushita H., and Minobe M. Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol 109 (1991) 1693-1698
10. Joshi A.B., Parrish II R.K., and Feuer W.F. 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma 14 (2005) 172-174
11. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113 (1995) 1479-1496
12. Gottlieb S. Deputy Commissioner for Medical and Scientific Affairs, Food and Drug Administration, Speech before Windhover's FDA/CMS Summit (2006). http://www.fda.gov/oc/speeches/2006/windhover1205.html Washington, DC, December 5. Available at http://www.fda.gov/oc/speeches/2006/windhover1205.html. Accessed Date: December 19, 2006.
13. Legal status of approved labeling for prescription drugs; prescribing for uses unapproved by the Food and Drug Administration: notice of Proposed rule making. Fed Register 37 (1972) 158
14. Information Sheets Guidance for Institutional Review Board and Clinical Investigators 1998 Update. Available at http://fda.gov/oc/phrt/irbs/offlabel.html. Accessed Date: December 23, 2006.
15. Yang Y.X., Lewis J.D., Epstein S., and Metz D.C. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296 (2006) 2947-2953